SON-2014

N/A

Report date: 2025/05/14 15:49:57

Base Information

Drug NameSON-2014
Drug Alias NameSON-2014
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin 18 modulatorsGranulocyte-macrophage colony-stimulating factor receptor subunit alpha inhibitors
TargetsInterleukin 18Granulocyte-macrophage colony-stimulating factor receptor subunit alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonnet Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A